Abstract

New functionalized homoleptic and heteroleptic zinc(II) and cadmium(II) dithiocarbamate complexes of formulae [Zn(cpebdtc)2] (1), [Zn(cpebdtc)2(py)] (2), [Cd(cpebdtc)2] (3), [Cd(cpebdtc)2(2,2ʹ-bipy)] (4) (where, cpebdtc = N-cyclopropyl-N-2-ethoxybenzyldithiocarbamate; py = pyridine and 2,2ʹ-bipy = 2,2ʹ-bipyridine) were synthesized and then characterized by CHNS analysis, IR, UV–Vis., 1H and 13C NMR spectroscopy. The molecular structures confirmed by X-ray crystallography revealed that complexes 1 and 2 adopt distorted tetrahedral and pentagonal geometry with ZnS4 and ZnS4N chromospheres respectively. Supramolecular networks are being sustained by CH…π and CC intermolecular interactions. Anti-leishmanial activity evaluation revealed the promising anti‑promastigote activity of complexes 1 and 2 with IC50 values 4.6 ± 0.41 and 3.37 ± 0.28 μg mL−1 respectively. The DNA binding study confirmed that complexes 1 and 2 bind effectively with Ct-DNA through groove binding/electrostatic interaction as suggested by hyperchromism and it was further validated by molecular docking. All the complexes showed potential antioxidant activity. TG analyses showed one step for 1, 3 and two step decomposition for 2, 4 complexes with the formation of binary ZnS (1, 2) and CdS (3, 4) materials. Complex 1 was utilized as a single source precursor to prepare ZnS nanoparticles. Single phase (rhombohedral) of ZnS nanomaterial was confirmed by X-ray diffraction analysis. TEM micrograph revealed spherical shape of ZnS nanoparticles with dimensions in the nanoscale (50–80 nm).

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call